Abstract
The last 50 years of molecular biological investigations into human adenoviruses (Ads) have contributed enormously to our understanding of the basic principles of normal and malignant cell growth. Much of this knowledge stems from analyses of the Ad productive infection cycle in permissive host cells. Also, initial observations concerning the transforming potential of human Ads subsequently revealed decisive insights into the molecular mechanisms of the origins of cancer and established Ads as a model system for explaining virus-mediated transformation processes. Today it is well established that cell transformation by human Ads is a multistep process involving several gene products encoded in early transcription units 1A (E1A) and 1B (E1B). Moreover, a large body of evidence now indicates that alternative or additional mechanisms are engaged in Ad-mediated oncogenic transformation involving gene products encoded in early region 4 (E4) as well as epigenetic changes resulting from viral DNA integration. In particular, studies on the transforming potential of several E4 gene products have now revealed new pathways that point to novel general mechanisms of virus-mediated oncogenesis. In this chapter we describe in vitro and in vivo assays to determine the transforming and oncogenic activities of the E1A, E1B, and E4 oncoproteins in primary baby rat kidney cells, human amniotic fluid cells and athymic nude mice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Endter C, Dobner T (2004) Cell transformation by human adenoviruses. Curr Top Microbiol Immunol 273:163–214
Williams JF, Zhang Y, Williams MA, Hou S, Kushner D, Ricciardi RP (2004) E1A-based determinants of oncogenicity in human adenovirus groups A and C. Curr Top Microbiol Immunol 273:245–288
Chinnadurai G (2004) Modulation of oncogenic transformation by the human adenovirus E1A C-terminal region. Curr Top Microbiol Immunol 273:139–161
White E (2001) Regulation of the cell cycle and apoptosis by the oncogenes of adenovirus. Oncogene 20:7836–7846
Täuber B, Dobner T (2001) Adenovirus early E4 genes in viral oncogenesis. Oncogene 20:7847–7854
Glaunsinger BA, Weiss RS, Lee SS, Javier RT (2001) Link of the unique oncogenic properties of adenovirus type 9 E4-ORF1 to a select interaction with the candidate tumor suppressor protein ZO-2. EMBO J 20:5578–5586
Thomas DL, Schaack J, Vogel H, Javier RT (2001) Several E4 region functions influence mammary tumorigenesis by human adenovirus type 9. J Virol 75:557–568
Nevels M, Rubenwolf S, Spruss T, Wolf H, Dobner T (2000) Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orf6 protein. J Virol 74:5168–5181
Nevels M, Täuber B, Kremmer E, Spruss T, Wolf H, Dobner T (1999) Transforming potential of the adenovirus type 5 E4orf3 protein. J Virol 73:1591–1600
Nevels M, Täuber B, Spruss T, Wolf H, Dobner T (2001) “Hit-and-run” transformation by adenovirus oncogenes. J Virol 75:3089–3094
Schiedner G, Hertel S, Kochanek S (2000) Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production. Hum Gene Ther 11:2105–2116
Weber K, Bartsch U, Stocking C, Fehse B (2008) A multicolor panel of novel lentiviral “gene ontology” (LeGO) vectors for functional gene analysis. Mol Ther 16:698–706
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Speiseder, T., Nevels, M., Dobner, T. (2014). Determination of the Transforming Activities of Adenovirus Oncogenes. In: Chillón, M., Bosch, A. (eds) Adenovirus. Methods in Molecular Biology, vol 1089. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-679-5_8
Download citation
DOI: https://doi.org/10.1007/978-1-62703-679-5_8
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-678-8
Online ISBN: 978-1-62703-679-5
eBook Packages: Springer Protocols